new glp-1 retatrutide 💊🔥 Retatrutide: The Most Powerful Weight-Loss Drug Yet? 🧬📊 Phase 3 clinical results are turning heads retatrutide, a next-generation triple-agonist targeting GLP-1, GIP and glucagon receptors, is showing unmatched levels of Some Providers Prescribe Unapproved Retatrutide

When an acute Vitamin B12 deficiency is present, quick action is needed

The rapid rise in type 1 and type 2 diabetes among the aging population will present significant issues for the German Diabetes Medications system in the years to come

doi:10.1016/S0140-6736(25)02105-1 Eli Lilly and Company, Zepbound

Prioritizing seven to nine hours per night helps regulate appetite and supports metabolic hormones

Tirzepatide already covers GLP-1 (so semaglutide adds redundancy)

2018 RCT showed that 5 grams of specific collagen peptides per day led to measurable improvements in BMD over 12 months in postmenopausal women with reduced bone density